Job Description
**Process Engineer II (Pharmaceutical Manufacturing)**
Manufacturing
Wilmington, Ohio, US
+ Added - 23/02/2026
Pay Rate Low: 90000 | Pay Rate High: 115000
_Our client is a global biopharmaceutical company seeking a ProcessEngineer II to support commercial and clinical pharmaceutical manuacturing, with a focus on oral solid dosage (OSD) products._
**Title:** Process Engineer II **(Pharmaceutical Manufacturing)**
**Salary** : $90-115K +Bonus
**Hours** : 1st shift ~8am-5pm M-F
**Location** : Onsite in Wilmington, OH (Excellent Relocation assistance provided if needed!)
**Summary**
The Process Engineer supports commercial and clinical pharmaceutical manufacturing, with a focus on oral solid dosage (OSD) products. This role is responsible for process scaleup and transfer, equipment selection and commissioning, and continuous improvement of manufacturing and packaging operations.
**Essential Functions**
+...
Manufacturing
Wilmington, Ohio, US
+ Added - 23/02/2026
Pay Rate Low: 90000 | Pay Rate High: 115000
_Our client is a global biopharmaceutical company seeking a ProcessEngineer II to support commercial and clinical pharmaceutical manuacturing, with a focus on oral solid dosage (OSD) products._
**Title:** Process Engineer II **(Pharmaceutical Manufacturing)**
**Salary** : $90-115K +Bonus
**Hours** : 1st shift ~8am-5pm M-F
**Location** : Onsite in Wilmington, OH (Excellent Relocation assistance provided if needed!)
**Summary**
The Process Engineer supports commercial and clinical pharmaceutical manufacturing, with a focus on oral solid dosage (OSD) products. This role is responsible for process scaleup and transfer, equipment selection and commissioning, and continuous improvement of manufacturing and packaging operations.
**Essential Functions**
+...
Ready to Apply?
Submit your application today and join our talented team at Astrix Technology.
Submit ApplicationJob Details
- Location Wilmington, OH
- Job Type Full-time
- Category other-general
- Posted Date June 24, 2026
- Application Deadline June 29, 2026